Clinical Trial News Archive - July 2022
July 1, 2022
July 4, 2022
- Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia
July 5, 2022
- FDA Grants Priority Review to Genentech’s Mosunetuzumab for People with Relapsed or Refractory Follicular Lymphoma
- Orexo's nasal adrenaline rescue medication OX640 enters clinical development
July 6, 2022
- Precision Medicine Approach Reverses Early-Stage Dementia
- Coherus and Junshi Biosciences Announce FDA Acceptance of Resubmission of BLA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
July 7, 2022
July 8, 2022
July 10, 2022
- Pivotal Data Demonstrate Once-Weekly Efanesoctocog Alfa Provides Superior Bleed Protection Compared to Prior Factor Prophylaxis
- Fitusiran Prophylaxis Reduced Bleeds by 61% in People with Hemophilia A or B, With or Without Inhibitors, Compared to Prior Factor or Bypassing Agent Prophylaxis
July 11, 2022
- Moderna's Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized Booster
- NIH Launches Clinical Trial of mRNA Nipah Virus Vaccine
- Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill
- FDA Clears LPCN 2101 IND for Adult Epilepsy Treatment
July 12, 2022
July 13, 2022
- Merck and Orion Announce Global Collaboration for the Development and Commercialization of ODM-208, an Investigational Steroid Synthesis Inhibitor for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Percentage of Overdose Deaths Involving Methadone Declined Between January 2019 and August 2021
- U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over
- miR Scientific announces commercial availability of the miR Sentinel Prostate Cancer Test
July 14, 2022
- A Type of ‘Step Therapy’ is an Effective Strategy for Diabetic Eye Disease
- Dupixent 3 Trial Shows Positive Results in Children 1 to 11 Years of Age with Eosinophilic Esophagitis
- Interferon Treatment May Reduce Severity of COVID-19 in People with Certain Genetic Factors
July 15, 2022
July 18, 2022
- NIH Study Finds Loss of ‘Youth’ Protein May Drive Aging in the Eye
- OliPass Moves Forward to Second Stage of Phase 2a Trial for Pain Killer OLP-1002
July 19, 2022
- Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time
- Innovent Announces Phase 2 Study of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Met Primary Endpoint
July 20, 2022
- FDA Authorizes Pharmacists to Prescribe Paxlovid
- DS-7300 Phase 2 Trial Initiated in Patients with Pretreated Extensive-Stage Small Cell Lung Cancer
- What Makes Omicron More Infectious Than Other COVID-19 Variants
July 21, 2022
July 22, 2022
- Vertex Advances VX-548 in Acute and Neuropathic Pain
- VistaGen Announces Topline Results from PALISADE-1 Phase 3 Clinical Trial for Investigational Drug PH94B
- MediciNova Initiates Clinical Evaluation of a New Parenteral Formulation of MN-166 (ibudilast)
July 26, 2022
- Instylla announces positive results from preclinical studies of Embrace Hydrogel Embolic System in hemorrhage models
- Janssen Announces New Data Supporting Safety and Efficacy of Rybrevant and Lazertinib Combination for Patients with Non-Small Cell Lung Cancer and EGFR Mutations
July 27, 2022
- Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLC
- AbbVie Submits Regulatory Applications to FDA and EMA for Rinvoq in Crohn's Disease
- New Insights into HIV Latent Cells Yield Potential Cure Targets
- Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
July 28, 2022
- The New England Journal of Medicine Publishes Positive Phase 2 Data on Litifilimab (BIIB059) in Cutaneous Lupus Erythematosus
- High-Tech Imaging Reveals Details About Rare Eye Disorder
- Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results
- Sound Pharma Initiates Enrollment in Pivotal Phase 3 Clinical Trial of SPI-1005 for the Treatment of Hearing Loss and Tinnitus in Meniere’s Disease
- Ionis announces positive topline results from Phase 2b clinical study of fesomersen, a potential novel anti-thrombotic treatment
July 29, 2022
- Sarepta Therapeutics Announces Intent to Submit an Accelerated Approval Biologics License Application for its Gene Therapy SRP-9001 to Treat Duchenne Muscular Dystrophy
- Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
July 31, 2022
Clinical trial results archive
- 2024
- January, February, March, April, May
- 2023
- January, February, March, April, May, June, July, August, September, October, November, December
- 2022
- January, February, March, April, May, June, July, August, September, October, November, December
- 2021
- January, February, March, April, May, June, July, August, September, October, November, December
- 2020
- January, February, March, April, May, June, July, August, September, October, November, December
- 2019
- January, February, March, April, May, June, July, August, September, October, November, December
- 2018
- January, February, March, April, May, June, July, August, September, October, November, December
- 2017
- May, June, July, August, September, October, November, December
- 2016
- October
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.